DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Estring (Estradiol Vaginal Ring) - Vulvovaginal Dryness - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Vulvovaginal Dryness (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Estring (Estradiol Vaginal Ring) where reactions include vulvovaginal dryness. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Estring side effects in 68 year old female

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: 68 year old female, weighing 77.1 kg (169.6 pounds)

Reactions: Product Quality Issue, Circumstance or Information Capable of Leading To Medication Error, Vulvovaginal Dryness

Drug(s) suspected as cause:
Estring
    Dosage: 2 mg, every 3 months
    Indication: Vulvovaginal Discomfort

Estring
    Indication: Vulvovaginal Dryness

Other drugs received by patient: Aspirin



Possible Estring side effects in 68 year old female

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: 68 year old female, weighing 77.1 kg (169.6 pounds)

Reactions: Product Quality Issue, Circumstance or Information Capable of Leading To Medication Error, Vulvovaginal Dryness

Drug(s) suspected as cause:
Estring
    Dosage: 2 mg, every 3 months
    Indication: Vulvovaginal Discomfort

Estring
    Indication: Vulvovaginal Dryness

Other drugs received by patient: Aspirin



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-13

Patient: female, weighing 45.4 kg (99.8 pounds)

Reactions: Drug Ineffective, Vulvovaginal Dryness, Vulvovaginal Pain, Vulvovaginal Discomfort

Drug(s) suspected as cause:
Estring



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-25

Patient: female, weighing 81.6 kg (179.6 pounds)

Reactions: Vulvovaginal Mycotic Infection, Vulvovaginal Dryness, Vulvovaginal Burning Sensation, Vulvovaginal Pain, Vulvovaginal Discomfort

Drug(s) suspected as cause:
Estring
    Dosage: 2 mg, unk
    Indication: Discomfort
    Start date: 2011-06-30

Estring
    Dosage: unk
    Indication: Vulvovaginal Burning Sensation

Estring
    Indication: Vulvovaginal Dryness

Other drugs received by patient: Acetylsalicylic Acid; Vitamin D; Prozac; Calcium; Zocor; Protonix; Levothyroxine; Lovaza



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-13

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Drug Ineffective, Vulvovaginal Dryness, Condition Aggravated

Drug(s) suspected as cause:
Estring

Other drugs received by patient: Allegra



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-01

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Drug Ineffective, Vulvovaginal Dryness, Condition Aggravated

Drug(s) suspected as cause:
Estring

Other drugs received by patient: Allegra



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-27

Patient: female

Reactions: Hot Flush, Malaise, Drug Ineffective, Vulvovaginal Dryness, Headache, Feeling Abnormal, Gastric Disorder, Muscle Spasms

Drug(s) suspected as cause:
Estring
    Dosage: 2 mg, unk
    Indication: Off Label Use
    Start date: 2012-01-05

Premarin

Other drugs received by patient: Synthroid



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-21

Patient: female

Reactions: Malaise, Hot Flush, Drug Ineffective, Vulvovaginal Dryness, Headache, Feeling Abnormal, Gastric Disorder, Muscle Spasms

Drug(s) suspected as cause:
Premarin

Estring
    Dosage: 2 mg, unk
    Indication: Off Label Use
    Start date: 2012-01-05

Other drugs received by patient: Synthroid



Possible Estring side effects in female

Reported by a pharmacist from United States on 2012-02-01

Patient: female

Reactions: Vulvovaginal Burning Sensation, Vulvovaginal Dryness

Drug(s) suspected as cause:
Estring

Other drugs received by patient: Celebrex



Possible Estring side effects in female

Reported by a lawyer from United States on 2012-01-23

Patient: female, weighing 62.1 kg (136.7 pounds)

Reactions: Pruritus, Dizziness Postural, Nipple Pain, Headache, Tricuspid Valve Incompetence, Cardiac Septal Defect, Malaise, Hot Flush, Balance Disorder, Vulvovaginal Dryness, Vulvovaginitis, Hemianopia Homonymous, Epistaxis, Dyspareunia, Back Pain, Mitral Valve Prolapse, Visual Field Defect, Peptic Ulcer, Ear Disorder, Cerebral Artery Thrombosis, Vaginal Discharge, Ataxia, Ovarian Cyst, Osteopenia, Paraesthesia, Dysmenorrhoea, Temporomandibular Joint Syndrome, Cerebral Infarction, Dehydration, Carotid Artery Disease, Osteoporosis, Gastrointestinal Inflammation, Hemiparesis, Fall, Constipation, Abdominal Pain Upper, Fibrocystic Breast Disease, Gastrooesophageal Reflux Disease, Lethargy, Lichen Sclerosus, Cataract, Nausea, Musculoskeletal Chest Pain, Cerebrovascular Accident, Amnesia, Hyperlipidaemia, Dysarthria, Atrophic Vulvovaginitis, Fibromuscular Dysplasia, Mitral Valve Incompetence, Visual Impairment, Flank Pain, Ejection Fraction Decreased, Vertigo, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Medroxyprogesterone Acetate
    Dosage: 10 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1995-04-01

Premarin
    Indication: Hormone Replacement Therapy

Estraderm
    Indication: Hormone Replacement Therapy
    End date: 1998-07-01

Estring
    Dosage: 2 mg, unk
    Indication: Hormone Replacement Therapy

Cycrin
    Dosage: 2.5 mg, unk
    Indication: Hormone Replacement Therapy

Other drugs received by patient: Plavix; Metoclopramide; Zocor; Premarin; Celexa; Zantac; Lipitor; Prilosec; Glucosamine



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-13

Patient: female

Reactions: Hot Flush, Drug Ineffective, Vulvovaginal Dryness, Headache, Feeling Abnormal

Drug(s) suspected as cause:
Premarin

Estring
    Dosage: unk
    Indication: Off Label Use
    Start date: 2012-01-05

Other drugs received by patient: Synthroid



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-12

Patient: female

Reactions: Hot Flush, Drug Ineffective, Vulvovaginal Dryness, Headache

Drug(s) suspected as cause:
Premarin
    Dosage: unk

Estring
    Dosage: unk



Possible Estring side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-11

Patient: female

Reactions: Hot Flush, Drug Ineffective, Vulvovaginal Dryness, Headache

Drug(s) suspected as cause:
Premarin
    Dosage: unk

Estring
    Dosage: unk



Possible Estring side effects in female

Reported by a physician from United States on 2012-01-09

Patient: female, weighing 62.1 kg (136.7 pounds)

Reactions: Pruritus, Dizziness Postural, Nipple Pain, Tricuspid Valve Incompetence, Headache, Cardiac Septal Defect, Hot Flush, Malaise, Balance Disorder, Vulvovaginal Dryness, Vulvovaginitis, Hemianopia Homonymous, Back Pain, Dyspareunia, Mitral Valve Prolapse, Peptic Ulcer, Visual Field Defect, Cerebral Artery Thrombosis, Ovarian Cyst, Osteopenia, Dysmenorrhoea, Temporomandibular Joint Syndrome, Cerebral Infarction, Dehydration, Carotid Artery Disease, Osteoporosis, Gastrointestinal Inflammation, Hemiparesis, Constipation, Fall, Abdominal Pain Upper, Fibrocystic Breast Disease, Gastrooesophageal Reflux Disease, Lichen Sclerosus, Lethargy, Cataract, Nausea, Musculoskeletal Chest Pain, Cerebrovascular Accident, Amnesia, Dysarthria, Hyperlipidaemia, Atrophic Vulvovaginitis, Fibromuscular Dysplasia, Flank Pain, Mitral Valve Incompetence, Visual Impairment, Ejection Fraction Decreased, Vertigo, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cycrin
    Dosage: 2.5 mg, unk
    Indication: Hormone Replacement Therapy

Premarin
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate
    Dosage: 10 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1995-04-01

Estring
    Dosage: 2 mg, unk
    Indication: Hormone Replacement Therapy

Estraderm
    Indication: Hormone Replacement Therapy
    End date: 1998-07-01

Other drugs received by patient: Prilosec; Zocor; Lipitor; Metoclopramide; Glucosamine; Zantac; Premarin; Celexa; Plavix



Possible Estring side effects in female

Reported by a pharmacist from United States on 2011-11-18

Patient: female

Reactions: Vulvovaginal Dryness, Vulvovaginal Pain

Drug(s) suspected as cause:
Estring

Other drugs received by patient: Simvastatin; Fosamax; Levothyroxine; Omeprazole



Possible Estring side effects in female

Reported by a pharmacist from United States on 2011-10-13

Patient: female

Reactions: Vulvovaginal Dryness, Vulvovaginal Pain

Drug(s) suspected as cause:
Estring

Other drugs received by patient: Fosamax; Simvastatin; Omeprazole; Levothyroxine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017